Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F24%3A00375155" target="_blank" >RIV/68407700:21460/24:00375155 - isvavai.cz</a>

Result on the web

<a href="https://doi.org/10.1016/S0140-6736(24)00757-8" target="_blank" >https://doi.org/10.1016/S0140-6736(24)00757-8</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/S0140-6736(24)00757-8" target="_blank" >10.1016/S0140-6736(24)00757-8</a>

Result language

angličtina

Original language name

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Original language description

Regular reporting on population health and causes of death is crucial for public health decision-making. Cause-specific mortality estimates help track progress in reducing mortality rates, especially after events like the COVID-19 pandemic. Analyzing mortality rates and life expectancy provides insights into the global impact of various causes of death over time. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 estimated mortality and years of life lost (YLLs) from 288 causes of death in 204 countries and 811 subnational locations from 1990 to 2021. Using 56,604 data sources, the study employed the Cause of Death Ensemble model to estimate cause-specific death rates. YLLs were computed by multiplying the number of deaths by the standard life expectancy at each age. Uncertainty intervals (UIs) were generated for each metric. The study included new age groups under five years, refined methods for sparse data, and pandemic-related mortality. In 2021, COVID-19 became the second-leading cause of death, displacing stroke. The highest death rates from COVID-19 were in sub-Saharan Africa and Latin America, while the lowest were in high-income regions and southeast Asia. Global life expectancy improved between 1990 and 2019 but dropped by 1.6 years from 2019 to 2021 due to the pandemic. Life expectancy gains varied by region, with southeast Asia, east Asia, and Oceania seeing the smallest reduction from COVID-19. Certain causes of death, like enteric infections and neonatal disorders, became more concentrated in specific regions since 1990. The COVID-19 pandemic disrupted long-standing gains in life expectancy, but progress continues against several leading causes of death. Regional variations in mortality and life expectancy highlight the need for targeted public health interventions. Understanding shifting mortality trends and successful interventions can inform policies to improve life expectancy globally.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30304 - Public and environmental health

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2024

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

The Lancet

ISSN

0140-6736

e-ISSN

1474-547X

Volume of the periodical

403

Issue of the periodical within the volume

10440

Country of publishing house

US - UNITED STATES

Number of pages

29

Pages from-to

2133-2161

UT code for WoS article

001270515100001

EID of the result in the Scopus database

2-s2.0-85191888198